History
  • No items yet
midpage
United States ex rel. Littlewood v. King Pharmaceuticals, Inc.
806 F. Supp. 2d 833
D. Maryland
2011
Read the full case

Background

  • Relator filed a qui tam action on April 16, 2010 alleging off-label promotion of FLECTOR Patch by King, Alpharma, and IBSA under the False Claims Act.
  • Government declined to intervene; relator dismissed the underlying suit with consent under Rule 41(a) in May 2011.
  • Government sought unsealing of the Amended Complaint and Amended Notice, but requested maintained seal for its extension motions.
  • Court explains FCA seal provisions: initial 60-day seal, potential extensions for good cause, and unsealing when government intervenes or declines.
  • Court finds strong public interest in disclosure; denies sealing, orders unsealing of Amended Complaint; addresses related Montana/settlement context and stays 30 days for appeal; cites multiple FCA seal authorities.
  • Court cites that FCA complaints are in government’s name and involve public funds, favoring public access to records.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Amended Complaint should remain sealed after non-intervention Littlewood opposes unsealing due to privacy and public-harm concerns Government argues public access should be preserved, but may seek sealing for extensions Amended Complaint should be unsealed
Whether the government motions for extension should be sealed Relator argues no basis to seal; public interest favors disclosure Government claims need for secrecy to protect ongoing investigation Seal on extension motions denied; unseal allowed for those documents
Whether the public has a right to the records given dismissal and lack of adjudication Relator relies on limited FCA context and non-adjudicatory posture to maintain seal Public access serves accountability; dismissal does not negate public interest in records Public access outweighed sealing; case unsealed in its entirety

Key Cases Cited

  • Under Seal v. Under Seal, 326 F.3d 479 (4th Cir. 2003) (presumption of public access can be overcome only by significant countervailing interests; FCA context not warranting permanent seal)
  • Bon Secours Cottage Health Servs. v. United States, 665 F.Supp.2d 782 (E.D. Mich. 2008) (no permanent sealing where government declines to intervene; strong public access presumption)
  • Mikes v. Straus, 846 F.Supp.2d 21 (S.D.N.Y. 1994) (protective orders to guard confidential investigation techniques; balance harm vs. need for disclosure)
  • Yannacopolous v. General Dynamics, 457 F.Supp.2d 854 (N.D. Ill. 2006) (disclosure appropriate for routine matters; protect non-parties and investigative methods when weighing seal)
  • Erickson v. Univ. of Wash., 339 F.Supp.2d 1124 (W.D. Wash. 2004) (unsealing appropriate where documents reveal routine investigation rather than sensitive methods)
  • O’Keefe v. McDonnell Douglas Corp., 902 F.Supp.189 (E.D. Mo. 1995) (denying seal if documents reveal routine investigative processes; protect only substantive details)
Read the full case

Case Details

Case Name: United States ex rel. Littlewood v. King Pharmaceuticals, Inc.
Court Name: District Court, D. Maryland
Date Published: Aug 29, 2011
Citation: 806 F. Supp. 2d 833
Docket Number: Civil Action No. ELH-10-973
Court Abbreviation: D. Maryland